Abstract:Radix Angelica sinensis is a Chinese medicinal herb that has been used extensively in the East for the treatment of cardiovascular diseases (CVDs). Angiogenesis plays an important role in the pathogenesis of CVDs. We hypothesized that Radix A. sinensis may contain angiogenesis modulators. In the current study, we investigated the effects of a volatile oil of Radix A. sinensis (VOAS) and n -butylidenephthalide (BP), one of the bioactive components in VOAS, on angiogenesis in vitro and in vivo. The results suggested that VOAS exerted anti-angiogenic effects by inhibiting human umbilical vein endothelial cell proliferation, migration and capillary-like tube formation on Matrigel. BP was also shown to be anti-angiogenic and its mechanisms were through inhibition of cell cycle progression and induction of apoptosis. Western blotting analysis indicated that the anti-angiogenic actions of BP were associated with the activation of p38 and ERK 1/2 but not SAPK/JNK and Akt signaling pathways. Further investigations showed that BP inhibited endothelial sprouting in an ex vivo mouse aortic ring model and was a potent inhibitor of the development of zebrafish subintestinal vessels in vivo. Our data using the volatile oil contrast with previous findings, which showed an aqueous extract of Radix A. sinensis was pro-angiogenic. This highlights the importance of identifying pro- and anti-angiogenic substances in Radix A. sinensis , not only for the development of novel angiogenesis modulators for the treatment of CVDs, but also to ensure the proper use of Radix A. sinensis as a nutraceutical.

Taspine isolated from Radix et Rhizoma Leonticis inhibits proliferation and migration of endothelial cells as well as chicken chorioallantoic membrane neovascularisation.

Suppression of tumor-induced angiogenesis by taspine isolated from Radix et Rhizoma Leonticis and its mechanism of action in vitro

Taspine downregulates VEGF expression and inhibits proliferation of vascular endothelial cells through PI3 kinase and MAP kinase signaling pathways.

Taspine Isolated from Radix Et Rhizoma Leonticis Inhibits Growth of Human Umbilical Vein Endothelial Cell (huvec) by Inducing Its Apoptosis

Inhibitory Effect of Taspine Derivative TAD1822-7 on Tumor Cell Growth and Angiogenesis Via Suppression of EphrinB2 and Related Signaling Pathways

Determination of Taspine Using HPLC–MS, and Its Effect on EGFR in A431 and HEK293/EGFR Cells

Activity of taspine isolated from Radix et Rhizoma Leonticis against estrogen-receptor-positive breast cancer.

Discovery of Novel Taspine Derivatives As Antiangiogenic Agents.

Tas13D Inhibits Growth of SMMC-7721 Cell Via Suppression VEGF and EGF Expression.

Synthesis and Preliminary Biological Evaluation of Novel Taspine Derivatives As Anticancer Agents.

Ta1722, an Anti-Angiogenesis Inhibitor Targeted on VEGFR-2 Against Human Hepatoma.

Antitumor Activity Of Taspine By Modulating The Egfr Signaling Pathway Of Erk1/2 And Akt In Vitro And In Vivo

A novel taspine derivative, HMQ1611, suppresses adhesion, migration and invasion of ZR-75-30 human breast cancer cells

Anti-angiogenic effect of tanshinone IIA involves inhibition of the VEGF/VEGFR2 pathway in vascular endothelial cells.

The natural compound n -butylidenephthalide derived from the volatile oil of Radix Angelica sinensis inhibits angiogenesis in vitro and in vivo

A Novel Taspine Analog, HMQ1611, Inhibits Growth of Non-Small Cell Lung Cancer by Inhibiting Angiogenesis.

New Potential Beneficial Effects of Actein, a Triterpene Glycoside Isolated from Cimicifuga Species, in Breast Cancer Treatment

FP3: a Novel VEGF Blocker with Antiangiogenic Effects in Vitro and Antitumour Effects in Vivo

Tanshinone IIA inhibits angiogenesis in human endothelial progenitor cells in vitro and in vivo

EFFECT OF TASPINE ON WOUND HEALING AND FIBROBLAST PROLIFERATION

Effects of taspine on proliferation and apoptosis by regulating caspase-3 expression and the ratio of Bax/Bcl-2 in A431 cells.